Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,836 papers from all fields of science
Search
Sign In
Create Free Account
Calcium Carbonate 356 MG / Magnesium Oxide 158 MG Chewable Tablet
Known as:
CALCIUM CARBONATE 356 mg / MAGNESIUM OXIDE 158 mg / CHOLECALCIFEROL 200 [iU] / CALCIUM CITRATE 77.9 mg / MAGNESIUM CITRATE 44.4 mg ORAL TABLET, CHEWABLE [Usana Active Calcium]
, calcium carbonate 356 MG (Ca 200 MG) / magnesium oxide 158 MG Chewable Tablet
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
Calcium Carbonate
Calcium Citrate
Calcium ion
Chewable Tablet
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
PEMBATALAN SERTIFIKAT HAK ATAS TANAH OLEH PENGADILAN TATA USANA NEGARA DENGAN ALASAN CACAT YURIDIS DALAM ASPEK WEWENANG
Yudhi Setiawan
,
Boedi Djatmiko Hadiatmodjo
2010
Corpus ID: 153855289
Attributive authority and delegation have to domicile which of vital importance to know an Legal Person or Administrative…
Expand
2008
2008
Risk Factors of Traumatic Injuries to the Upper Incisors
S. Meštrović
,
D. Pandurić
,
S. Milošević
,
Dunja Ribarić
2008
Corpus ID: 263764174
Purpose: The purpose of this study was to determine the frequency of the upper incisors crown trauma and its relationship to…
Expand
2005
2005
Vodoravni poloæaj usana u ispitanika klase I i klase II/1 u dobi od 12 godina
Acta Stomat Croat
2005
Corpus ID: 74535638
1995
1995
Penerapan Anggaran Operasional bagi Manajemen Badan Usaha sebagai Alat Perencanaan dan Pengendalian pada PT. Romos Inti Cosmetic Industries di Surabaya
Eva Vera Andalas
1995
Corpus ID: 191652012
Perencanaan dan pengendal1an adalah dua hal yang t1dak dapat dipisahkan. Perencanaan merupakan penjabaran tujuan yang 1ngin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE